首页> 外文期刊>Journal of intensive care medicine >Use of drotrecogin alfa in necrotizing fasciitis: a case report and pharmacologic review.
【24h】

Use of drotrecogin alfa in necrotizing fasciitis: a case report and pharmacologic review.

机译:drotrecogin alfa在坏死性筋膜炎中的应用:病例报告和药理学审查。

获取原文
获取原文并翻译 | 示例
           

摘要

Necrotizing fasciitis (NF) is a devastating subset of necrotizing soft tissue infections that requires prompt diagnosis and treatment. Although often occurring in patients with impaired host defense mechanisms (diabetes mellitus, systemic immunosuppression, malignancy, etc.), NF may also present in the immunocompetent following a cutaneous lesion or break. Patients with NF often progress to a systemic inflammatory response syndrome or multiorgan system failure that demands advanced critical care practices. We present a case of NF in an immunocompetent patient and the subsequent use of drotrecogin alfa (Xigris). A review of the pharmacologic treatment of streptococcal NF is included. The addition of drotrecogin alfa to operative debridement and penicillin G/clindamycin therapy may be a useful adjunct in the treatment of necrotizing fasciitis due to group A streptococcus.
机译:坏死性筋膜炎(NF)是坏死性软组织感染的毁灭性子集,需要及时诊断和治疗。尽管通常在宿主防御机制受损(糖尿病,全身免疫抑制,恶性肿瘤等)的患者中发生,但在皮肤病变或破裂后,NF也可能存在于免疫功能正常的患者中。患有NF的患者通常会进展为需要高级重症监护实践的全身性炎症反应综合征或多器官系统衰竭。我们介绍了一个有免疫能力的患者的NF病例,随后使用了drotrecogin alfa(Xigris)。包括对链球菌NF的药物治疗的综述。在术中清创术中加用德罗古丁α和青霉素G /克林霉素治疗可能是治疗A组链球菌性坏死性筋膜炎的有用辅助手段。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号